GETI-B:STO
Getinge publ AB
SEK 240,10
arrow_upward
+0,08%(+0,20) 1D
14 ສ.ຫ., 17 ໂມງ 29 ນາທີ 54 ວິນາທີ GMT+2 · SEK
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GETI-B...
Open
SEK 239,90
High
SEK 242,20
Low
SEK 239,60
Mkt. cap
໖໑,໐໒ ຕື້
Avg. vol.
໖໐໖,໕໓ ພັນ
Volume
໔໔໖,໙໖ ພັນ
Dividend
໑,໙໘%
Quarterly dividend
SEK 1,19
Ex-dividend date
22 ມ.ສ. 2026
P/E ratio
໒໔,໔໖
52-wk high
SEK 242,20
52-wk low
SEK 175,90
EPS
SEK 9,82
Shares outstanding
໒໕໔,໑໕ ລ້ານ
No. of employees
໑໒ ພັນ
Open
SEK 239,90
High
SEK 242,20
Low
SEK 239,60
Mkt. cap
໖໑,໐໒ ຕື້
Avg. vol.
໖໐໖,໕໓ ພັນ
Volume
໔໔໖,໙໖ ພັນ
Dividend
໑,໙໘%
Quarterly dividend
SEK 1,19
Ex-dividend date
22 ມ.ສ. 2026
P/E ratio
໒໔,໔໖
52-wk high
SEK 242,20
52-wk low
SEK 175,90
EPS
SEK 9,82
Shares outstanding
໒໕໔,໑໕ ລ້ານ
No. of employees
໑໒ ພັນ
Profile
Getinge AB is a publicly traded Swedish medical technology company. The company produces and distributes medical products and equipment for the healthcare and life sciences industries. The company is divided into three business areas: Life Science, Acute Care Therapies, and Surgical Workflows. The group employs approximately 12,000 people worldwide. The CEO of the company is Mattias Perjos, and the chairman of the board is Johan Malmquist. With a sales share of around 40%, the United States is by far the most important market for the company due to significantly higher prices and margins there. China and various Western European countries follow. Wikipedia
About Getinge publ AB
AI content may include mistakes. Learn more